CN Patent

CN105073101A — 具有高含量非索非那定的固体单元及其制备方法

Assigned to Sanofi Aventis France · Expires 2015-11-18 · 10y expired

What this patent protects

本发明涉及旨在以固体单元形式(诸如片剂)用于口服给药的药物组合物，其包含高含量的非索非那定和/或其至少一种药用盐，本发明还涉及制备固体单元的热熔方法。

USPTO Abstract

本发明涉及旨在以固体单元形式(诸如片剂)用于口服给药的药物组合物，其包含高含量的非索非那定和/或其至少一种药用盐，本发明还涉及制备固体单元的热熔方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN105073101A
Jurisdiction
CN
Classification
—
Expires
2015-11-18
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis France
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.